Portfolio comparison
Novartis AG vs Kite Pharma
Side-by-side portfolio analysis — patents indexed, year ranges, and activity timeline.
Top Patents2 enriched
US 10472419· 2019
How Novartis Engineered Antibodies to Block the TIM-3 Immune Checkpoint
US 7740842· 2010
How to Keep High-Concentration Antibody Medicines Stable in Liquid Form
Activity by Decade
2010s2
Company B
Kite Pharma
Patents indexed
1
Year range
2026
Most recent
2026
biotechpharmaceuticalgene_editingimmunotherapy
Top Patents1 enriched
US 12600775· 2026
Treating a Specific Lymphoma with Modified T Cells
Activity by Decade
2020s1
How to use
Bookmark a comparison URL to save it. Format: /compare/companies?a=[slug]&b=[slug]. Also see patent-level comparison.